Clinical Trials
6 trialsNCT01385826 2025-09-08
ADJUVITE
Assistance Publique - Hôpitaux de Paris
Phase 2/3 Completed
NCT02334748 2020-05-19
A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies
Novartis
Phase 3 Completed
NCT03769558 2020-03-20
A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
Bristol-Myers Squibb
Completed
NCT03780959 2019-08-02
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
Amgen
Phase 2/3 Completed
NCT00964210 2011-04-15
HPV
Murdoch Childrens Research Institute
Phase 3 Completed
NCT00001862 2008-03-04
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed